色素上皮衍生因子作为子宫肌瘤新型多靶点治疗的研究
研究采用人平滑肌瘤细胞系与Eker大鼠子宫平滑肌瘤ELT-3细胞系进行体外实验,并将ELT-3细胞注射至无胸腺裸雌鼠诱导异位肌瘤病灶后给予重组色素上皮衍生因子(PEDF)治疗。结果显示重组PEDF可激活ERK、下调血管内皮生长因子及雌激素受体α和β的mRNA与蛋白、抑制细胞增殖,并降低小鼠肌瘤生长速率、使肿瘤缩小。作者认为重组PEDF可能是子宫肌瘤的一种新型有效生理性治疗。
要点
- 平滑肌瘤细胞系表达PEDF及其受体,重组PEDF可激活ERK并呈时间依赖性。
- 重组PEDF下调血管内皮生长因子mRNA与蛋白及雌激素受体α和β的mRNA,抑制细胞增殖。
- 荷瘤小鼠中重组PEDF降低肌瘤生长速率并使肿瘤缩小。
核心结论
- 本研究提示重组PEDF可能是子宫肌瘤的一种新型有效生理性治疗,平行靶向血管内皮生长因子和雌激素受体等肌瘤病理生物学关键环节,并在动物模型中限制肌瘤生长和最终大小。
研究设计与样本
- 体外模型使用人平滑肌瘤细胞系和Eker大鼠子宫平滑肌瘤ELT-3细胞系,向培养基中加入重组PEDF以检查细胞靶点。
- 体内模型使用无胸腺裸雌鼠,注射ELT-3细胞诱导异位肌瘤病灶后给予重组PEDF治疗。
主要发现
- 两种平滑肌瘤细胞系均检测到PEDF及其受体的RNA表达,并检测到PEDF受体表达。
- 向平滑肌瘤细胞系培养基中加入重组PEDF后,ERK呈时间依赖性激活,血管内皮生长因子mRNA和蛋白以及雌激素受体α和β的mRNA下调,细胞增殖受抑制。
- 对荷肌瘤小鼠给予重组PEDF后,肌瘤生长速率降低,肿瘤更小。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does recombinant pigment epithelium derived factor (PEDF) have potential in treating uterine fibroids? DESIGN: In-vitro models that used human leiomyoma and Eker rat uterine leiomyoma (ELT-3) cell lines. The ELT-3 cell line was used to examine cellular targets after adding recombinant PEDF to the culture media. Athymic nude female mice were used as an in-vivo model. They were injected with ELT-3 cells to induce ectopic fibroid lesions, then treated with recombinant PEDF. RESULTS: RNA expression of PEDF and its receptors was found in both leiomyoma cell lines, as well as the expression of PEDF receptors. Addition of recombinant PEDF to the culture medium of leiomyoma cell lines activated ERK in a time-dependent manner, induced down-regulation of vascular endothelial growth factor mRNA and protein, as well as the mRNAs of oestrogen receptors alpha and beta and inhibited cellular proliferation. Treatment of mice-bearing fibroids with recombinant PEDF reduced fibroid growth rate and resulted in smaller tumours. CONCLUSIONS: This study suggests that recombinant PEDF is a putative novel potent physiological treatment for uterine fibroids. It targets several cornerstones of fibroid pathobiology in parallel, including vascular endothelial growth factor and oestrogen receptors, which are needed for vascularization, and restricts fibroid growth and final size in an animal model.
引用
- Bar-Joseph H, Hikri E, Chuderland D, et al. Pigment epithelium derived factor as a novel multi-target treatment for uterine fibroids. Reprod Biomed Online. 2020. PMID: 32532667. doi:10.1016/j.rbmo.2020.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。